Greater patient access to immuno-oncology therapies-what can policymakers do?
European Cancer Patient Coalition, Brussels B-1000, Belgium.
Francesco
F
de Lorenzo
The Health Policy Partnership, London W1W 5NA, UK.
Suzanne
S
Wait
Ege University, Department of Medical Oncology, Izmir 35100, Turkey.
Burçak
B
Karaca
Association for Cancer Immunotherapy (CIMT), Mainz D-55116, Germany.
Cedrik M
CM
Britten
Scientific Institute of Public Health, B-1050, Belgium.
Marc
M
van den Bulcke